Home > Chemicals and Materials > Specialty Chemicals > Custom Synthesis > avidin market
Get a free sample of Avidin Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Avidin Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The avidin industry is expanding, particularly in developing regions. The rising demand for avidin can be attributed to the rising healthcare expenditure, growing research & development activities, and the adoption of sophisticated technologies. In emerging nations, the growing pharmaceutical and biotechnology sectors are projected to open new avenues for avidin manufacturers & suppliers. The integration of technology and automation into various industries, including the automation of avidin-based assays, such as the use of robotic systems for high-throughput screening & analysis, is impacting market growth.
The trend toward increased efficiency, accuracy, and productivity is driving the adoption of automated systems that incorporate avidin in various applications. The move toward sustainable agriculture, improved crop yields, and genetically modified organisms is likely to fuel the demand for avidin in agricultural applications. Similarly, the rising focus on animal health & welfare is expected to contribute to the growing use of avidin applications in the veterinary sector.
The market size off avidin was valued at USD 220 million in 2022 and will reach USD 350 million by 2032, attributed to advancements in various biotechnological applications as well as the rising need for precise & efficient research tools.
The streptavidin segment accounted for a market value of around USD 150 million in 2022, owing to its strong binding affinity for biotin, which forms the basis of the biotin-streptavidin system.
Vector Laboratories, Thermo Fisher Scientific, Merck KGaA (Sigma-Aldrich), Aviva Systems Biology, BioVectra, Cell Signaling Technology, and Avidity.
U.S. dominated North America avidin market with a revenue of USD 62.7 million in 2022 and will expand at a significant pace from 2023